Pancreatic cancer is one of the most aggressive cancers. Today there are chemo and radiation
drugs used for some pancreatic cancers. Rarely is surgery performed.
But there are medical doctors who have had great success treating pancreatic cancer for the last 100 years. Don't believe me? Here you go:
The embryologist Dr. John Beard proposed in 1906 that pancreatic proteolytic digestive enzymes represent the body's main defense against cancer. www.alternative-doctor.com/cancer/beard
William Donald Kelley, a dentist from Grapevine, Texas, cured himself of pancreatic cancer in the sixties, largely using Beard's theories, and went on to develop a nutritionally-based, do-it-yourself home cure for cancer which is probably over ninety per cent effective in patients who have not been overly destroyed by chemotherapy and orthodox treatments
Dr. Kelley went on to treat cancer patients for twenty years with a complicated nutritional therapy based on Beard’s enzyme treatment. His work was documented and subsequently researched by Dr Nicholas Gonzalez. Dr Gonzalez identified 22 patients from Dr. Kelley's group. For all of these patients, Dr. Gonzalez obtained complete medical records, including death certificates for those who were deceased. He interviewed all surviving patients repeatedly and at length, and interviewed family members in the case of those who had died.
Ten of these patients had visited Kelley only once and had never followed the protocol: these individuals had been discouraged from proceeding largely because of the negative influence of family and physicians who thought Kelley to be an outright fraud. This population, with a median survival of only 60 days, served as a convenient control. Little did they know, their reluctance to try enzyme therapy would result in their use as negative control group data
Among the remaining 12 patients, Dr. Gonzalez found a number who had survived far beyond what would be expected for the disease, including one patient with pancreatic cancer to the liver who had, when last contacted, been alive over twenty years from her original diagnosis.
Later Gonzalez visited Kelley whereupon Kelley made available all of his records, well over 10,000 patients, and was encouraged by Kelley to contact any and all of them. On his trip to Texas, Gonzalez was astonished to find case after case of appropriately diagnosed advanced metastatic cancer patients who were healthy and active five, ten, and 15 years after diagnosis. http://www.dr_gonzalez.com/maver_article.htm
In July 1993, Dr. Gonzalez was approached by Nestle Corporation to pursue a pilot study of enzyme therapy methods in ten patients suffering inoperable adenocarcinoma of the pancreas, with survival as the endpoint. He was told that if three of ten patients lived a year, that would be considered a positive result. Nestec (the Nestle Corporation) agreed to fund the trial, which began in January 1994.
The study was published in the June 1999 issue (Volume 33, Number 2) of Nutrition and Cancer. Of 11 patients followed in the trial, 8 of 11 suffered stage IV disease.
- 3 died within one year
- 3 lived more than one year
- 1 lived 2 years
- 2 lived 3 years
- 2 lived longer than 4 years
In comparison, in a trial of the drug gemcitabine, of 126 patients with pancreatic cancer not a single patient lived longer than 19 months.
This astounding success was accomplished with digestive enzymes alone. Just imagine if these patients had added enzyme rich foods and measured their personal pH to achieve alkalinity. In other words, what if the enzyme therapy were carried over into diet?
Dr Nicholas Gonzalez continues to treat cancer patients in New York City and is lauded by his patients including Suzanne Somers, the bioidentical hormone proponent as well as attacked by his peers.
